abstract |
A capsule comprising a pharmaceutical formulation of 5-methyl-1-phenyl-2- (1H) -pyridone, wherein said pharmaceutical formulation comprises, by weight, 5 to 30% of pharmaceutically acceptable excipients and 70 to 95% of 5-methyl-1-phenyl-2- (1 H) -pyridone, and wherein the pharmaceutically acceptable excipients comprise povidone. |